Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$332M |
| 2 |
ExxonMobil
XOM
|
+$283M |
| 3 |
Verizon
VZ
|
+$165M |
| 4 |
Yum China
YUMC
|
+$137M |
| 5 |
Chevron
CVX
|
+$129M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$941M |
| 2 |
Dimensional International Core Equity 2 ETF
DFIC
|
+$862M |
| 3 |
Dimensional International High Profitability ETF
DIHP
|
+$427M |
| 4 |
Dimensional International Small Cap Value ETF
DISV
|
+$421M |
| 5 |
Apple
AAPL
|
+$219M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.86% |
| 2 | Technology | 15.28% |
| 3 | Industrials | 12.71% |
| 4 | Healthcare | 11.82% |
| 5 | Consumer Discretionary | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Castle Biosciences
CSTL
$1.12B
| $6.22M | ﹤0.01% |
238,488
+46,410
| +24% | +$1.3M |
|
|
LL
2352
DELISTED
LL Flooring Holdings, Inc.
LL
| $6.18M | ﹤0.01% |
891,351
-151,357
| -15% | -$1.36M |
|
2353
FIVE9
FIVN
$2.58B
| $6.17M | ﹤0.01% |
82,240
-27,418
| -25% | -$2.66M |
|
2354
Braskem
BAK
$713M
| $6.11M | ﹤0.01% |
627,555
+270
| +0% | +$3.37K |
|
|
KZR
2355
DELISTED
Kezar Life Sciences
KZR
| $6.09M | ﹤0.01% |
70,777
+32,373
| +84% | +$3.15M |
|
2356
Cerence
CRNC
$369M
| $6.08M | ﹤0.01% |
386,111
-22,728
| -6% | -$510K |
|
2357
Carter Bankshares
CARE
$706M
| $6.08M | ﹤0.01% |
377,660
+55,787
| +17% | +$872K |
|
2358
PLDT
PHI
$3.88B
| $6.05M | ﹤0.01% |
239,604
-5,687
| -2% | -$167K |
|
|
TPIC
2359
DELISTED
TPI Composites
TPIC
| $6.04M | ﹤0.01% |
535,233
-155,000
| -22% | -$2.45M |
|
|
GBT
2360
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $6.01M | ﹤0.01% |
88,277
-1,137
| -1% | -$62.7K |
|
2361
Arcutis Biotherapeutics
ARQT
$3.33B
| $6M | ﹤0.01% |
313,943
+1,335
| +0.4% | +$30.2K |
|
|
DCT
2362
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $5.99M | ﹤0.01% |
505,488
-15,793
| -3% | -$209K |
|
2363
Twin Disc
TWIN
$359M
| $5.97M | ﹤0.01% |
520,407
+8,617
| +2% | +$85K |
|
|
PFSW
2364
DELISTED
PFSweb, Inc.
PFSW
| $5.97M | ﹤0.01% |
640,397
+69,246
| +12% | +$714K |
|
2365
DMC Global
BOOM
$128M
| $5.96M | ﹤0.01% |
373,281
-106,961
| -22% | -$2.17M |
|
2366
Korea Electric Power
KEP
$14.5B
| $5.96M | ﹤0.01% |
875,593
-27,245
| -3% | -$214K |
|
|
TDAY
2367
USA Today Co
TDAY
$928M
| $5.95M | ﹤0.01% |
3,891,200
-1,200,982
| -24% | -$2.91M |
|
2368
Matrix Service
MTRX
$282M
| $5.95M | ﹤0.01% |
1,437,642
-110,266
| -7% | -$565K |
|
2369
Vaxcyte
PCVX
$8.98B
| $5.94M | ﹤0.01% |
247,329
+169,807
| +219% | +$4.3M |
|
2370
Banco Bradesco
BBD
$36.8B
| $5.93M | ﹤0.01% |
1,609,428
+382
| +0% | +$1.35K |
|
|
SUMO
2371
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $5.91M | ﹤0.01% |
+788,416
| New | +$6.29M |
|
2372
Immunovant
IMVT
$7.78B
| $5.91M | ﹤0.01% |
1,058,459
+112,979
| +12% | +$552K |
|
2373
Marqeta
MQ
$1.65B
| $5.91M | ﹤0.01% |
207,336
+189,417
| +1,057% | +$6.3M |
|
2374
Vera Bradley
VRA
$122M
| $5.88M | ﹤0.01% |
1,954,279
-308,209
| -14% | -$1.24M |
|
2375
Acadia Pharmaceuticals
ACAD
$4.73B
| $5.83M | ﹤0.01% |
356,415
-136,513
| -28% | -$2.21M |
|
Similar funds
Dimensional Fund Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Dimensional Fund Advisors held 3,606 positions worth $260B, down 6.6% from $279B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dimensional Fund Advisors's Q3 2022 filing shows 143 new, 1,920 increased, 1,329 reduced and 119 closed positions. Its largest new stake was Yum China: 2,857,283 shares worth $135M. The largest sale was Dimensional Emerging Markets Core Equity 2 ETF, an estimated $941M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
- Dimensional Fund Advisors's largest Q3 2022 buy was Yum China: 2,857,283 shares worth $135M.
- Dimensional Fund Advisors added most to Meta Platforms (Facebook) in Q3 2022, an estimated $332M increase.
- Dimensional Fund Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $219M.
- Dimensional Fund Advisors fully exited Dimensional Emerging Markets Core Equity 2 ETF in Q3 2022, selling an estimated $941M.
- Dimensional Fund Advisors's ten largest holdings make up 11% of its $260B portfolio in Q3 2022.
- Dimensional Fund Advisors opened 143 new positions and closed 119 in Q3 2022.
- Dimensional Fund Advisors's portfolio value fell 6.6% quarter-over-quarter to $260B.
Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.